Results 161 to 170 of about 2,465 (209)
Electroencephalogram criticality in cognitive impairment: a monitoring biomarker? [PDF]
Cogn NeurodynTseriotis VS +4 more
europepmc +1 more source
A library of colorectal cancer immunogenic glycopeptides: A step towards novel theragnostics applications [PDF]
Eliana Janine de Paiva Soares
core
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 2022
Precision medicine (or personalized medicine) is an intriguing, and still involving part of modern medicine. Theragnostics is a combination of therapies and diagnostics targeting pathophysiological processes at molecular level using radiopharmaceuticals.
Evangelista L. +2 more
openaire +2 more sources
Precision medicine (or personalized medicine) is an intriguing, and still involving part of modern medicine. Theragnostics is a combination of therapies and diagnostics targeting pathophysiological processes at molecular level using radiopharmaceuticals.
Evangelista L. +2 more
openaire +2 more sources
Critical Care Medicine, 2009
Theragnostics is a treatment strategy that combines therapeutics with diagnostics. It associates both a diagnostic test that identifies patients most likely to be helped or harmed by a new medication, and targeted drug therapy based on the test results.
Frederic Pene
exaly +3 more sources
Theragnostics is a treatment strategy that combines therapeutics with diagnostics. It associates both a diagnostic test that identifies patients most likely to be helped or harmed by a new medication, and targeted drug therapy based on the test results.
Frederic Pene
exaly +3 more sources
Magnetic nanoparticles for theragnostics [PDF]
Advanced Drug Delivery Reviews, 2009 Engineered magnetic nanoparticles (MNPs) represent a cutting-edge tool in medicine because they can be simultaneously functionalized and guided by a magnetic field. Use of MNPs has advanced magnetic resonance imaging (MRI), guided drug and gene delivery, magnetic hyperthermia cancer therapy, tissue engineering, cell tracking and bioseparation ...
Thomas R Pisanic
exaly +3 more sources
Theragnostics in Neuroendocrine Tumors
PET Clinics, 2021Several studies have demonstrated the effectiveness of somatostatin receptor (SSTR)-targeted imaging for diagnosis, staging, evaluating the possibility of treatment with cold somatostatin analogs, as well peptide receptor radionuclide therapy (PRRT), and evaluation of treatment response.
Margarida, Rodrigues +2 more
openaire +2 more sources
Theragnostics in prostate cancer
The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 2022Prostate-specific membrane antigen (PSMA) is a molecular target for both imaging diagnostics and therapeutics, i.e., a theragnostics target. There has been a growing body of evidence supporting PSMA theragnostics approaches in the management of prostate cancer (PCa) for tailored precision medicine. Tumor characterization through PSMA-ligand PET imaging
Andrea, Farolfi +3 more
openaire +2 more sources
Theragnostic in neuroendocrine tumors
The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 2022In the last few decades, the incidence and prevalence of neuroendocrine tumors has been increasing. The theragnostic approach, that allows the diagnosis and treatment of different neoplasms with the same ligand, is a typical nuclear medicine tool. Applied for years, is also pivotal in neuroendocrine tumors (NETs) where it has improved the diagnostic ...
Marini I. +12 more
openaire +2 more sources
Shifting emphasis from pharmacogenomics to theragnostics [PDF]
Nature Biotechnology, 2006 What will be the role of theragnostic patents in upstream and downstream biomarker research?
Bryn Williams-Jones, Stephen J Glatt
exaly +3 more sources
Theragnostic radionuclides: a clinical perspective
The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 2022The concept of theragnostics goes back to the earliest days of nuclear medicine, with [123I/131I]iodide in thyroid disease and [123I/131I]MIBG in phaeochromocytoma being examples in long-term use. However, in recent years there has been a great expansion in the application of theragnostics, beginning with [68Ga/177Lu]-labelled somatostatin peptides for
Jacek, Koziorowski, James, Ballinger
openaire +2 more sources